Sharon Bio-Medicine Ltd-$ (Delisted) share news and announcements
BSE: 532908Pharmaceuticals & Biotechnology
Last traded ₹3.30 on 28 Mar 2019
Delisted on 20 Feb 2024.
Sharon Bio-Medicine Ltd-$ share news and announcements
831 announcements, routine notices left out, newest first. Page 15 of 17.
Oct 2013
30 Oct · Management
1. Mr. Drunal Shah, has resigned as a Director of the Company with effect from September 01, 2013. 2. Mr. Madhav Manohar Sapre ....30 Oct · Management
1.Mr. Drunal Shah, has resigned as a Director of the Company with effect from September 01, 2013. 2. Mr. Madhav Manohar Sapre is appointed as the Additional Director w.e.f. September 01, 2013.30 Oct · Board meeting
To adopt and publish Unaudited Financial results for the quarter September 30, 2013.
Aug 2013
13 Aug · Board meeting
To consider inter alia, adoption of Audited Financial Result for the Quarter and Year ended as on June, 30, 2013.
Jul 2013
Jun 2013
11 Jun · SA- FORD - GLP Toxicology approval in ARGENTINA
Company's Toxicology Laboratory namely SA-FORD, which is approved by Organisation of Economic Development and Cooperation (OECD) countries ....
May 2013
3 May · Board meeting
To consider inter alia, to consider and adopt the Un-Audited Financial Result for the Quarter ended On March 31, 2013.
Mar 2013
6 Mar · Updates
Sharon Bio-Medicine Limited had informed the Exchange regarding approval from Bondholders for rollover of FCCB USD 16.50 Mn for another 5 years. The Company has now informed the Exchange that the said announcement should be read as follows:"The FCCB of USD 16.5 Million which had matured on December 04, 2012, which was further extended by bondholders till February 28, 2013, the bondholders have approved the restructuring proposal which involves extension of tenor of the existing Bonds for 5 years and issue of additional Bonds in lieu of the accrued interest till date. Accordingly, the Company has applied for the RBI approval for the said restructuring proposal as per the current ECB Guidelines."6 Mar · Updates on Approval from Bondholders for rollover of FCCB USD 16.50 Mn for another 5 years
With reference to the earlier announcement dated March 05, 2013 regarding approval from Bondholders for rollover of FCCB USD 16.50 Mn for another 5 years, Sharon Bio-Medicine Ltd has now ....5 Mar · Updates
FCCB of USD 16.5 Million which had matured on December 04, 2012, which was further extended by bondholders till February 28, 2013 has been rolled over with the consent of bondholders for another 5 years. Accordingly, the Company have applied to Reserve Bank of India (RBI) as per the guidelines of ECB for their consent.5 Mar · Approval from Bondholders for rollover of FCCB USD 16.50 Mn for another 5 years
FCCB of USD 16.5 Million which had matured on December 04, 2012, which was further extended by bondholders till February 28, 2013 has been ....
Feb 2013
Jan 2013
23 Jan · Board meeting
Inter alia, to consider and adopt the Un-Audited Financial Result for the Quarter ended on December 31, 2012.22 Jan · FCCBs
Pursuant to our earlier intimation to the Stock Exchange on December 24, 2012 regarding extending the date for negotiation for conversion/ redemption or rollover of the Bonds which were due on December 04, 2012 to February 28, 2013, the board of directors at its meeting held today has resolved to convene an extra-ordinary general meeting to be held on February 16, 2013 for the approval of the shareholders on the said rollover of the existing FCCBs22 Jan · Board meeting
With reference to the earlier announcement dated December 24, 2012, regarding extending the date for negotiation for conversion/ redemption or rollover of the Bonds which were due on December ....
Dec 2012
26 Dec · Meeting
Annual General Meeting of the Members of the Company will be held on December 29, 2012.26 Dec · Meeting
The 23rd Annual General Meeting (AGM) of the Company will be held on December 29, 2012 at Plot No. W-34, W-34/1, MIDC, Taloja, Dist - Raigad, ....24 Dec · Updates
24 Dec · Corporate action
Register of Members and the Share Transfer Books of the Company will remain closed from January 07, 2013 to January 08, 2013 for the purpose of ascertaining eligibility of the members for entitlement of final dividend of Rs. 1.80/- per Equity Share of Rs. 10/- each.24 Dec · Dividend
Register of Members & Share Transfer Books of the Company will remain closed from January 07, 2013 to January 08, 2013 (both days inclusive) ....
Nov 2012
Oct 2012
30 Oct · Board meeting
To consider inter alia, adoption of Un-Audited Financial Results for the Quarter ended on September 30, 2012.23 Oct · Dividend
Board of Directors of the Company at its meeting held on October 22, 2012, inter alia, had resolved and recommended dividend @ Rs. 1.80 ....22 Oct · Dividend
Board of Directors of the Company at the Meeting held on October 22, 2012 had resolved and recommended dividend @ Rs. 1.80 per share subject to approval of shareholders at the Annual General Meeting.16 Oct · Board meeting
Inter alia, to consider the followings: (1) Adoption of Audited Balance Sheet as on June 30, 2012 and Statement of Profit & Loss for the year ended as on that date together with Report of Directors and Auditors thereon. (2) Recommendation of dividend on 10556900 equity shares of Rs. 10/- each fully paid up for the year ended 2011-12, subject to approval of the members at the ensuing Annual General Meeting.(3) The Dividend as recommended by the Board, if approved at the members at the Annual General meeting will be paid on or after the date of Annual General Meeting, the exact date will be intimated as soon as the date of Annual General Meeting is decided.15 Oct · Board meeting
Meeting of the Board of Directors of the Company will be held on October 22, 2012, inter alia, to consider the followings: 1. Adoption ....
Sep 2012